Long-Acting MIC-1/GDF15 Molecules to Treat Obesity: Evidence From Mice to Monkeys

Science Translational Medicine - United States
doi 10.1126/scitranslmed.aan8732
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

GDF15 Deficiency Promotes High Fat Diet-Induced Obesity in Mice

PLoS ONE
Multidisciplinary
2018English

Pmh49 - Launching Long Acting Products to Treat Opioid Use Disorder: Are Payers Willing to Pay Premium Price?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) as a Novel Diagnostic Serum Biomarker in Pancreatic Ductal Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Long Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

How Long to Treat With Bisphosphonates?

Health
2015English

To Treat or Not to Treat? And How to Treat? Two Questions Whose Answers Are Far Removed From Evidence Informed Practice in Child Psychiatry

European Child and Adolescent Psychiatry
DevelopmentalMental HealthPediatricsEducational PsychologyPhilosophyPerinatologyPsychiatryMedicineChild Health
2013English

Drugs Acting on SUR1 to Treat CNS Ischemia and Trauma

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2008English

Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Obstructive Sleep Apnea Without Obesity Is Common and Difficult to Treat: Evidence for a Distinct Pathophysiological Phenotype

Journal of Clinical Sleep Medicine
PulmonaryNeurologyRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy